Tactile Medical

Tactile Medical

TCMD
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $125M

Market Cap: $587.4MFounded: 1995HQ: Minneapolis, United States

Overview

Tactile Medical is a commercial-stage, publicly-traded medical device company with a mission to reveal and treat underserved chronic conditions, enabling at-home self-care. The company has established a strong commercial footprint in the US, driven by its flagship Flexitouch and next-generation Nimbl pneumatic compression systems for lymphedema, supported by a robust body of clinical evidence and a direct-to-patient commercial model. Its strategy focuses on expanding awareness, improving patient access, and innovating its product portfolio to drive growth in its core markets while exploring new indications.

LymphedemaLipedemaChronic Venous InsufficiencyChronic Respiratory Conditions

Technology Platform

Platform centered on advanced pneumatic compression devices (Flexitouch, Nimbl) for lymphatic stimulation and High Frequency Chest Wall Oscillation (AffloVest) for airway clearance, designed for at-home patient use.

Funding History

2
Total raised:$125M
Debt$50M
IPO$75M

Opportunities

Large, underserved patient populations (e.g., ~20M Americans with lymphedema) and a secular shift towards value-based, home-based care create a significant growth runway.
Expanding awareness, securing broader insurance coverage, and launching next-generation connected devices are key growth levers.

Risk Factors

Heavy reliance on third-party payer reimbursement, particularly Medicare, subjects the business to policy changes.
Market adoption is constrained by under-diagnosis, and competition from alternative therapies and devices could intensify.

Competitive Landscape

Competes with other pneumatic compression device makers (e.g., Lympha Press, Bio Compression) and respiratory vest providers. Differentiation is achieved through strong clinical evidence, a focus on mimicking manual lymphatic drainage, and a comprehensive commercial support model.

Company Timeline

1995Founded

Founded in Minneapolis, United States

2016IPO

IPO — $75.0M

2021Debt

Debt: $50.0M